Report cover image

Global & Thailand Cancer Therapeutics Market to 2031

Published Jun 04, 2025
Length 100 Pages
SKU # BMKS20063517

Description

Thailand is witnessing a growing shift toward more precise, personalized, and less toxic cancer treatments. The demand for immunotherapies and targeted therapies has significantly increased, with several new treatment options entering the market. Immune checkpoint inhibitors like Keytruda (pembrolizumab) and Opdivo (nivolumab) have become more accessible in Thailand, offering promising options for patients with melanoma, non-small cell lung cancer (NSCLC), bladder cancer, and other cancers. These therapies enhance the immune system's ability to detect and attack cancer cells, providing new hope for patients with advanced-stage cancers who previously had limited options.

The Thai government has actively worked to improve access to oncology treatments through the Universal Coverage Scheme (UCS), which, as of 2023, covers chemotherapy, radiation therapy, and certain targeted therapies for all citizens. This program plays a vital role in making life-saving treatments more accessible, particularly for those living in rural or economically disadvantaged areas. Additionally, the government has taken steps to ease the financial strain of cancer care by negotiating with pharmaceutical companies to lower the cost of key cancer medications.

Table of Contents

100 Pages
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Data Triangulation and Validation:
4. Thailand Cancer Therapeutics Market Landscape
4.1 Overview
4.2 Ecosystem Analysis
4.2.1 List of Vendors in the Value Chain
5. Cancer Therapeutics Market Key Market Dynamics
5.1 Cancer Therapeutics Market – Key Market Dynamics
5.2 Market Drivers
5.3 Market Restraints
5.4 Market Opportunities
5.5 Future Trends
5.6 Impact of Drivers and Restraints
6. Thailand Cancer Therapeutics Market – Analysis
6.1 Thailand Cancer Therapeutics Market Revenue (US$ Million), 2021–2031
6.2 Thailand Cancer Therapeutics Market Revenue and Forecast Analysis
7. Thailand Cancer Therapeutics Market Analysis – by Therapy Types
7.1 Thailand Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Therapy Types
8. Thailand Cancer Therapeutics Market Analysis – by Indications
8.1 Thailand Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Indications
9. Thailand Cancer Therapeutics Market Analysis – by Distribution Channel
9.1 Thailand Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Distribution Channel
10. Competitive Landscape
10.1 Heat Map Analysis by Key Players
10.1 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.2 Partnerships and Collaborations
11.2 Other Developments
12. Company Profiles
12.1 Bristol-Myers Squibb Co
12.1. 1 Key Facts
12.1. 2 Business Description
12.1. 3 Products and Services
12.1. 4 Financial Overview
12.1. 5 SWOT Analysis
12.1. 6 Key Developments
12.2 AbbVie Inc
12.2. 1 Key Facts
12.2. 2 Business Description
12.2. 3 Products and Services
12.2. 4 Financial Overview
12.2. 5 SWOT Analysis
12.2. 6 Key Developments
12.3 Johnson & Johnson
12.3. 1 Key Facts
12.3. 2 Business Description
12.3. 3 Products and Services
12.3. 4 Financial Overview
12.3. 5 SWOT Analysis
12.3. 6 Key Developments
12.4 F. Hoffmann-La Roche Ltd
12.4. 1 Key Facts
12.4. 2 Business Description
12.4. 3 Products and Services
12.4. 4 Financial Overview
12.4. 5 SWOT Analysis
12.4. 6 Key Developments
12.5 Pfizer Inc
12.5. 1 Key Facts
12.5. 2 Business Description
12.5. 3 Products and Services
12.5. 4 Financial Overview
12.5. 5 SWOT Analysis
12.5. 6 Key Developments
12.6 AstraZeneca Plc
12.6. 1 Key Facts
12.6. 2 Business Description
12.6. 3 Products and Services
12.6. 4 Financial Overview
12.6. 5 SWOT Analysis
12.6. 6 Key Developments
12.7 Merck KGaA
12.7. 1 Key Facts
12.7. 2 Business Description
12.7. 3 Products and Services
12.7. 4 Financial Overview
12.7. 5 SWOT Analysis
12.7. 6 Key Developments
12.8 Novartis AG
12.8. 1 Key Facts
12.8. 2 Business Description
12.8. 3 Products and Services
12.8. 4 Financial Overview
12.8. 5 SWOT Analysis
12.8. 6 Key Developments
12.9 Astellas Pharma Inc
12.9. 1 Key Facts
12.9. 2 Business Description
12.9. 3 Products and Services
12.9. 4 Financial Overview
12.9. 5 SWOT Analysis
12.9. 6 Key Developments
12.10 Eli Lilly and Co
12.10. 1 Key Facts
12.10. 2 Business Description
12.10. 3 Products and Services
12.10. 4 Financial Overview
12.10. 5 SWOT Analysis
12.10. 6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
TABLE OF TABLES
Table 1. Thailand Cancer Therapeutics Market Segmentation
Table 2. List of Vendors
Table 3. Thailand Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million)
Table 4. Thailand Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million)
Table 5. Thailand Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Therapy Types
Table 6. Thailand Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy Types
Table 7. Thailand Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 8. Thailand Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 9. Thailand Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel
Table 10. Thailand Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel
Table 11. List of Abbreviations
TABLE OF FIGURES
Figure 1. Impact Analysis of Drivers and Restraints
Figure 2. Thailand Cancer Therapeutics Market Revenue, (US$ Million), 2021–2031
Figure 3. Heat Map Analysis by Key Players
Figure 4. Company Positioning and Concentration

Search Inside Report

How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.